Zim Laboratories shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters30.30%−0.06 pts

Foreign investors (FII)0.17%+0.14 pts

Domestic institutions (DII)1.19%−0.14 pts

of which mutual funds1.18%+0.11 pts

Public68.34%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZIMLAB₹141.26

Zim Laboratories Limited

· Pharma & Health

₹ CrorePeersANUHPHR VALIANTLAB AHCL ALBERTDAVD WANBURY HALEOSLABS BAJAJHCARE THEMISMEDMcap ₹756 Cr

Holding % of Total Shares 12 Months Ending	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 13/03/2026	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	33.26	33.26	33.26	33.26	33.26	33.26	30.30	30.35	30.36	30.30
FII / FPI	0.00	0.21	0.01	0.03	—	0.02	0.00	—	0.03	0.17
DII	0.10	0.24	0.24	0.24	0.24	0.20	0.07	0.07	1.33	1.19
Mutual Funds	0.00	0.00	0.00	—	—	—	—	—	1.07	1.18

Latest: 2026-09-30 · 19 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.